PURIPEG Trademark of Mountain View Pharmaceuticals, Inc. - Serial Number 76313134

PURIPEG Trademark

Trademark Overview

On Monday, September 10, 2001, a trademark application was filed for PURIPEG with the United States Patent and Trademark Office. The USPTO has given the PURIPEG trademark a serial number of 76313134. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 20, 2012. This trademark is owned by Mountain View Pharmaceuticals, Inc.. The PURIPEG trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in humans and animals for the treatment of cancer, gout, metabolic disease, inherited disorders

General Information

Serial Number	76313134
Word Mark	PURIPEG
Filing Date	Monday, September 10, 2001
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, July 20, 2012
Registration Number	3029623
Registration Date	Tuesday, December 13, 2005
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, July 2, 2002

Trademark Statements

Goods and Services	pharmaceutical preparations for use in humans and animals for the treatment of cancer, gout, metabolic disease, inherited disorders
Pseudo Mark	PURE I PEG

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, July 20, 2012
Primary Code	005
First Use Anywhere Date	Tuesday, March 9, 2004
First Use In Commerce Date	Saturday, June 25, 2005

Trademark Owner History

Party Name	Mountain View Pharmaceuticals, Inc.
Party Type	30 - Original Registrant
Legal Entity Type	03 - Corporation
Address	Menlo Park, CA 940251821

Party Name	Mountain View Pharmaceuticals, Inc.
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	Menlo Park, CA 940251821

Party Name	Mountain View Pharmaceuticals, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Menlo Park, CA 940251821

Trademark Events

Event Date	Event Description
Friday, July 20, 2012	CANCELLED SEC. 8 (6-YR)
Tuesday, December 13, 2005	REGISTERED-PRINCIPAL REGISTER
Thursday, November 3, 2005	LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, October 28, 2005	ASSIGNED TO LIE
Saturday, October 22, 2005	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 5, 2005	STATEMENT OF USE PROCESSING COMPLETE
Friday, September 23, 2005	USE AMENDMENT FILED
Friday, September 23, 2005	TEAS STATEMENT OF USE RECEIVED
Wednesday, June 1, 2005	EXTENSION 5 GRANTED
Wednesday, March 23, 2005	EXTENSION 5 FILED
Wednesday, March 23, 2005	TEAS EXTENSION RECEIVED
Thursday, September 30, 2004	EXTENSION 4 GRANTED
Thursday, September 23, 2004	EXTENSION 4 FILED
Thursday, September 23, 2004	TEAS EXTENSION RECEIVED
Thursday, July 29, 2004	CASE FILE IN TICRS
Monday, April 26, 2004	ASSIGNED TO EXAMINER
Thursday, April 1, 2004	EXTENSION 3 GRANTED
Monday, March 22, 2004	EXTENSION 3 FILED
Monday, March 22, 2004	PAPER RECEIVED
Tuesday, September 16, 2003	EXTENSION 2 GRANTED
Tuesday, September 16, 2003	EXTENSION 2 FILED
Monday, September 22, 2003	PAPER RECEIVED
Friday, August 29, 2003	EXTENSION 1 GRANTED
Friday, March 7, 2003	EXTENSION 1 FILED
Saturday, August 30, 2003	DIVISIONAL PROCESSING COMPLETE
Friday, March 7, 2003	DIVISIONAL REQUEST RECEIVED
Friday, March 7, 2003	PAPER RECEIVED
Tuesday, September 24, 2002	NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 1, 2002	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 2, 2002	PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2002	NOTICE OF PUBLICATION
Tuesday, March 12, 2002	APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 24, 2002	CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 27, 2001	NON-FINAL ACTION MAILED
Friday, November 23, 2001	ASSIGNED TO EXAMINER
Friday, November 16, 2001	ASSIGNED TO EXAMINER

Related Keywords

puripeg metabolic disease inherited disorders gout cancer preparations humans animals treatment